Marpai Inc Stock Price, News & Analysis

Marpai, Inc. (Nasdaq: MRAI) is expanding into the education market by establishing a center of excellence to enhance health plan services for school districts. Currently, Marpai is serving four Texas school districts, impacting 39 schools. The company's AI-driven services aim to improve member health and reduce costs, utilizing predictive deep learning to guide members to quality care and prevent costly health events. Collaborating with Synolo and USEBSG, Marpai's initiative emphasizes a proactive approach to healthcare for educators and their families.

Marpai, Inc. (NASDAQ: MRAI) announced that its management and directors have collectively purchased $1.1 million in common stock. Board member Damien Lamendola increased his holdings, acquiring 225,000 warrants at $4 per share, injecting an additional $900,000 into the company. Notable purchases include 25,000 shares by Chairman Yaron Eitan and 17,500 shares by CEO Edmundo Gonzalez, with prices ranging from $4.17 to $4.42 per share. These actions reflect confidence in Marpai's AI-driven solutions in the self-funded health insurance market.

Marpai, Inc. (NASDAQ: MRAI) reported financial results for Q3 2021, achieving net revenue of approximately $4.8 million, marking a 36% sequential increase over the first half of 2021. Revenue growth reflects a rise in covered employees by 23% to 25,136. Operating expenses surged to $9.5 million, resulting in a net loss of $4.8 million. The company also closed its IPO, generating $28.75 million in gross proceeds. For Q4 2021, Marpai anticipates revenue guidance of $5.6 million to $5.8 million, indicating 17% to 21% sequential growth.

Marpai, Inc. (Nasdaq: MRAI), a deep learning technology firm in the self-funded health insurance market, has scheduled a conference call for December 9 at 4:15 p.m. ET to discuss its third quarter financial results for the period ending September 30, 2021. The call will follow the release of the Q3 results after market close. Marpai aims to enhance healthcare cost management and health outcomes through advanced predictive technologies. Interested parties can access a replay of the call until December 23 and a recording of the webcast will be available for 90 days on their investor relations site.

Marpai, Inc. (Nasdaq: MRAI), a technology firm innovating in third-party administration within the healthcare sector, has announced the hiring of two marketing directors, Christina DiBona as Marketing Director for Member and Client Engagement, and Marcella Withers as Marketing Director for Brokers, Employers, and Partners. DiBona brings 20 years of marketing expertise, while Withers has over 16 years in brand strategy. CEO Edmundo Gonzalez highlighted the importance of these roles in enhancing member engagement and driving business growth amidst their deployment of deep learning technologies.

Marpai, Inc. (Nasdaq: MRAI) launched its new Gaps in Care service aimed at promoting preventive health among members by sending personalized reminders for annual exams and screenings. This service expands Marpai's AI-driven offerings designed to reduce chronic illnesses and health costs in the self-funded market, a sector representing over $1 trillion in health claims. Marpai serves over 50,000 members and collaborates with major networks like Aetna and Cigna, leveraging technology to improve health outcomes and lower expenses.

Marpai, Inc. (NASDAQ: MRAI) will be featured on The RedChip Money Report® on Bloomberg TV on Nov. 6 at 7 p.m. ET. The program focuses on small-cap investing and includes interviews with public company executives. Marpai utilizes deep learning technology to enhance healthcare third party administration, serving over 60 self-funded organizations and 40,000 members across the U.S. The interview aims to showcase the company’s innovations in reducing costs and improving health outcomes.

Marpai, Inc. (NASDAQ: MRAI) has successfully closed its initial public offering, selling 7,187,500 shares of common stock at $4.00 each, which resulted in gross proceeds of $28.75 million, excluding underwriting discounts and offering expenses. The offering included 937,500 shares sold through the underwriters' over-allotment option. ThinkEquity served as the sole book-running manager for this offering. The company utilizes deep learning technology to improve healthcare management for self-funded markets, serving over 60 self-funded companies and 40,000 members nationwide.

Marpai, Inc. (Nasdaq: MRAI) has priced its initial public offering (IPO) at $4.00 per share, raising gross proceeds of $25 million through the sale of 6,250,000 shares. An additional 937,500 shares may be purchased by underwriters to cover over-allotments. The shares are set to trade on the Nasdaq Capital Market starting October 27, 2021, with the offering closing on October 29, 2021. Marpai utilizes deep learning technology to transform third-party administration in the healthcare self-funded market, serving over 40,000 members across the U.S.